Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin and Ropivacaine TPI for Myofascial Pain Syndrome
NCT07866443Phase 4Completed
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Mar 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 4, randomised trial of pregabalin in myofascial pain syndrome (MPS) (2 arms), sponsored by National and Kapodistrian University of Athens. Primary endpoint: Numerical Rating Scale for Pain Intensity at 3 months. Started Mar 2025; status: completed.
02
Drugs
pregabalin
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT07866443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07866443.